NO932947L - Antimikrobielt middel - Google Patents

Antimikrobielt middel

Info

Publication number
NO932947L
NO932947L NO932947A NO932947A NO932947L NO 932947 L NO932947 L NO 932947L NO 932947 A NO932947 A NO 932947A NO 932947 A NO932947 A NO 932947A NO 932947 L NO932947 L NO 932947L
Authority
NO
Norway
Prior art keywords
campylobacter pylori
disease caused
antimicrobial agent
preventing
bacterium
Prior art date
Application number
NO932947A
Other languages
English (en)
Other versions
NO932947D0 (no
NO307689B1 (no
Inventor
Masaru Sato
Shigeru Souda
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of NO932947D0 publication Critical patent/NO932947D0/no
Publication of NO932947L publication Critical patent/NO932947L/no
Publication of NO307689B1 publication Critical patent/NO307689B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
NO932947A 1992-08-21 1993-08-19 Anvendelse av et antimikrobielt middel NO307689B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP24404292 1992-08-21

Publications (3)

Publication Number Publication Date
NO932947D0 NO932947D0 (no) 1993-08-19
NO932947L true NO932947L (no) 1994-02-22
NO307689B1 NO307689B1 (no) 2000-05-15

Family

ID=17112856

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932947A NO307689B1 (no) 1992-08-21 1993-08-19 Anvendelse av et antimikrobielt middel

Country Status (10)

Country Link
US (1) US5916904A (no)
EP (1) EP0585722B1 (no)
AT (1) ATE137969T1 (no)
CA (1) CA2104531C (no)
DE (1) DE69302646T2 (no)
DK (1) DK0585722T3 (no)
ES (1) ES2087623T3 (no)
FI (1) FI933681A (no)
GR (1) GR3019917T3 (no)
NO (1) NO307689B1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5504082A (en) * 1992-06-01 1996-04-02 Yoshitomi Pharmaceutical Industries, Ltd. Pyridine compound and pharmaceutical compostions
US6673827B1 (en) 1999-06-29 2004-01-06 The Uab Research Foundation Methods of treating fungal infections with inhibitors of NAD synthetase enzyme
US6861448B2 (en) 1998-01-14 2005-03-01 Virtual Drug Development, Inc. NAD synthetase inhibitors and uses thereof
WO1999036422A1 (en) * 1998-01-14 1999-07-22 The Uab Research Foundation Methods of synthesizing and screening inhibitors of bacterial nad synthetase enzyme, compounds thereof, and methods of treating bacterial and microbial infections with inhibitors of bacterial nad synthetase enzyme
CA2341506A1 (en) * 1998-08-25 2000-03-02 The Uab Research Foundation Inhibitors of bacterial nad synthetase
US6174902B1 (en) 1999-04-28 2001-01-16 Sepracor Inc. R-rabeprazole compositions and methods
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6316020B1 (en) * 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
EP1611901B1 (en) * 2003-03-13 2013-07-10 Eisai R&D Management Co., Ltd. Preventive or remedy for teeth grinding

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI90544C (fi) * 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
ATE114114T1 (de) * 1989-02-10 1994-12-15 Takeda Chemical Industries Ltd Verwendung von benzimidazol-derivaten als antibakterielle mittel.
JPH0348680A (ja) * 1989-07-18 1991-03-01 Yoshitomi Pharmaceut Ind Ltd 抗菌剤

Also Published As

Publication number Publication date
FI933681A0 (fi) 1993-08-20
EP0585722B1 (en) 1996-05-15
FI933681A (fi) 1994-02-22
GR3019917T3 (en) 1996-08-31
DE69302646D1 (de) 1996-06-20
CA2104531C (en) 1999-01-05
DK0585722T3 (da) 1996-08-05
US5916904A (en) 1999-06-29
ES2087623T3 (es) 1996-07-16
CA2104531A1 (en) 1994-02-22
EP0585722A1 (en) 1994-03-09
ATE137969T1 (de) 1996-06-15
NO932947D0 (no) 1993-08-19
NO307689B1 (no) 2000-05-15
DE69302646T2 (de) 1996-10-31

Similar Documents

Publication Publication Date Title
NO932947L (no) Antimikrobielt middel
OA09334A (fr) "Dérivés d'acides aminés".
DE69529670D1 (de) Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen
ATE141605T1 (de) Thienotriazoldiazepinverbindungen und deren pharmazeutische anwendungen
AU4175893A (en) Treatment of inflammatory bowel disease
KR890003378A (ko) 혐기성균에 대해 항균작용을 갖는 나프티리딘 화합물
KR880007070A (ko) 백내장 치료용 약학 조성물
ATE38982T1 (de) Guanidinmethylcyclohexancarbonsaeure-derivate, verfahren zur herstellung und pharmazeutische mittel.
FI923662A (fi) Terapeutiska medel
DE3872425D1 (de) Substituierte tetrahydroisochinolin-verbindungen, ihre herstellung und diese enthaltende pharmazeutische mittel.
DE69619088D1 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus
KR900016130A (ko) 2-피리딜메틸티오 유도체 및 궤양 치료제
ES2116528T3 (es) Nuevo compuesto, la leustroducsina h, su preparacion y su utilizacion terapeutica.
DK653687A (da) Middel til behandling af nyresygdomme
NO881798D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.

Legal Events

Date Code Title Description
MK1K Patent expired